ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 145 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,615 | -8.1% | 1,767 | 0.0% | 0.00% | – |
| Q2 2023 | $2,845 | -7.5% | 1,767 | +66.5% | 0.00% | – |
| Q1 2023 | $3,077 | -72.0% | 1,061 | -68.3% | 0.00% | – |
| Q4 2022 | $10,985 | -62.1% | 3,349 | -56.3% | 0.00% | – |
| Q3 2022 | $29,000 | +2800.0% | 7,664 | +6394.9% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 118 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 118 | -43.5% | 0.00% | – |
| Q4 2021 | $3,000 | -25.0% | 209 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | +33.3% | 209 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 209 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | -25.0% | 209 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | 0.0% | 209 | -23.7% | 0.00% | – |
| Q3 2020 | $4,000 | +33.3% | 274 | +31.1% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 209 | -11.1% | 0.00% | – |
| Q1 2020 | $2,000 | -60.0% | 235 | -27.9% | 0.00% | – |
| Q4 2019 | $5,000 | 0.0% | 326 | -4.7% | 0.00% | – |
| Q3 2019 | $5,000 | – | 342 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,610,000 | 11.42% |
| Redmile Group, LLC | 6,048,123 | $9,737,478 | 0.37% |
| Baupost Group | 9,773,616 | $15,736 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 170,000 | $273,700 | 0.27% |
| MAVERICK CAPITAL LTD | 6,290,713 | $10,128,048 | 0.22% |
| 683 Capital Management, LLC | 1,000,000 | $1,610,000 | 0.12% |
| WASATCH ADVISORS LP | 8,283,981 | $13,337,209 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $845,250 | 0.08% |
| STALEY CAPITAL ADVISERS INC | 750,000 | $1,207,500 | 0.06% |
| XTX Topco Ltd | 136,841 | $220,314 | 0.04% |